Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 104 entries
View as:

Utility of the Clamping Bean Test (CBT) for Covert Hepatic Encephalopathy Screening

Phase: N/A Priority: Normal
NCT ID: NCT06367127 Org: User:
Start: 10/09/23 End: 12/31/24 Due: 12/31/25

En Bloc Resection Versus Separation Surgery Combined With Radiotherapy for the Treatment of Spinal Oligometastatic Tumor.

Phase: N/A Priority: Normal
NCT ID: NCT06120426 Org: User:
Start: 07/01/23 End: 07/01/27 Due: 07/01/28

Quantitative Assessment of Lumbar Facet Joint Degeneration, A Retrospective Study.

Phase: N/A Priority: Normal
NCT ID: NCT06786611 Org: User:
Start: 09/01/20 End: 07/31/24 Due: 07/31/25

Low-dose Rifaximin in the Treatment of Covert Hepatic Encephalopathy

Phase: N/A Priority: Normal
NCT ID: NCT03077217 Org: User:
Start: 05/01/17 End: 05/31/20 Due: 05/31/21

A Phase 2 Clinical Trial to Evaluate Zanubrutinib Combined With BR (Bendamustine/Rituximab) Regimen in Subjects With Newly-diagnosed Waldenström's Macroglobulinemia

Phase: N/A Priority: Normal
NCT ID: NCT05979948 Org: User:
Start: 08/01/23 End: 12/01/25 Due: 12/01/26

Extraperitoneal SINgle-port rObotic-assisted Radical Prostatectomy (RARP) Versus Transperitoneal Multi-port RARP in the Treatment Of Prostate Cancer (SINO-TOP)

Phase: N/A Priority: Normal
NCT ID: NCT06238713 Org: User:
Start: 01/08/24 End: 12/31/25 Due: 12/31/26

Regorafenib Plus PD-1 Inhibitor in Patients With Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04110093 Org: User:
Start: 03/01/19 End: 08/31/21 Due: 08/31/22

Efficacy and Safety of LC-Z300-01 on Proteinuria in Diabetic Patients

Phase: N/A Priority: Normal
NCT ID: NCT06686758 Org: User:
Start: 04/30/25 End: 05/31/26 Due: 05/31/27

Pancreatic Cancer and Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT06585072 Org: User:
Start: 03/03/25 End: 09/01/26 Due: 09/01/27

UCMSCs Combined With Standard Therapy for the Treatment of Newly Diagnosed Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT06407297 Org: User:
Start: 05/23/24 End: 05/01/26 Due: 05/01/27

mNGS for Therapy of Urinary Infectious Diseases

Phase: N/A Priority: Normal
NCT ID: NCT05624476 Org: User:
Start: 01/01/23 End: 12/31/23 Due: 12/31/24

WFA+M2BP in Evaluation of Portal Hypertension and Clinical Outcome in Patients With Liver Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT03195634 Org: User:
Start: 06/30/17 End: 12/31/18 Due: 12/31/19

Arsenic Trioxide for Structural p53 Mutations

Phase: N/A Priority: Normal
NCT ID: NCT04695223 Org: User:
Start: 01/01/21 End: 10/31/21 Due: 10/31/22

Study of FasT CAR-T GC012F Injection NDMM Patients

Phase: N/A Priority: Normal
NCT ID: NCT05840107 Org: User:
Start: 05/04/23 End: 09/30/25 Due: 09/30/26

MSC303 Subcutaneous Injection for the Treatment of Immunologic Glomerular Disease.

Phase: N/A Priority: Normal
NCT ID: NCT07000292 Org: User:
Start: 06/20/25 End: 02/20/27 Due: 02/20/28

Anterior Spinal Canal Reconstruction and Fusion Surgery for Treating Degenerative Cervical Kyphosis With Stenosis

Phase: N/A Priority: Normal
NCT ID: NCT04806360 Org: User:
Start: 09/01/22 End: 12/30/23 Due: 12/30/24

Anti-CD19-CD3E-CAR-T Cells in Relapsed/Refractory Autoimmune Disease

Phase: N/A Priority: Normal
NCT ID: NCT06373081 Org: User:
Start: 04/20/24 End: 04/15/26 Due: 04/15/27

5-MTHF Supplementation for Treatment of Type 1 Diabetes Patients

Phase: N/A Priority: Normal
NCT ID: NCT06930144 Org: User:
Start: 04/30/25 End: 04/30/27 Due: 04/30/28

Autologous Regenerative Islet Transplantation for Insulin-dependent Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT05294822 Org: User:
Start: 09/30/19 End: 12/31/23 Due: 12/31/24

a Study of CT0596 in Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Plasma Cell Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT06718270 Org: User:
Start: 12/11/24 End: 12/31/27 Due: 12/31/28

Evaluation of Ultrasensitive Chromosomal Aneuploidy Detection for Detecting Minimal Residual Disease in Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT04122092 Org: User:
Start: 10/20/19 End: 10/20/22 Due: 10/20/23

The Efficacy and Safety of Alverine in the Treatment of Portal Hypertension in Patients With Liver Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT06470386 Org: User:
Start: 06/30/24 End: 11/30/25 Due: 11/30/26

The Aim of This Study is to Assess the Efficacy and Safety of Chidamide, Regorafenib in Combination With Iparomlimab and Tuvonralimab for the Treatment of Advanced Colorectal Cancer in Third-line Therapy and Subsequent Lines.

Phase: N/A Priority: Normal
NCT ID: NCT06930118 Org: User:
Start: 04/10/25 End: 09/30/27 Due: 09/30/28

Effects of Denosumab on Bone Fusion in Osteoporotic Patients After Lumbar Fusion

Phase: N/A Priority: Normal
NCT ID: NCT05203588 Org: User:
Start: 10/09/21 End: 10/31/23 Due: 10/31/24

Duration and Adverse Events of Non-cuffed Catheter in Patients With Hemodialysis

Phase: N/A Priority: Normal
NCT ID: NCT02264964 Org: User:
Start: 01/31/15 End: 12/31/17 Due: 12/31/18